Delivery Order SPE2DB20D1100-SPE2DB24FA1R7
Award Date
2/9/24
Potential Completion Date
2/12/24
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, to provide 4,563,628,875 units of Tamsulosin HCl 0.4 mg capsules. The $3,049.48 order has a completion date of February 13, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division based in Conshohocken, Pennsylvania, is the prime contractor. This delivery order is part of a larger indefinite...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,697.77 to provide 1,000 units of the generic pharmaceutical drug Tamsulosin HCl 0.4 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg. The $5,622.40 award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to support Department of Defense military treatment facilities...
The U.S. Defense Logistics Agency (DLA) awarded a $1,902.08 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,310,884 capsules of Tamsulosin HCL 0.4 mg. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,001,477 capsules of the generic drug tamsulosin hydrochloride 0.4 mg. The $3,324.39 contract has a performance period through March 19, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract between...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $65,411.87 to provide 4,564,298,844 capsules of Tamsulosin HCL 0.4 mg. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 17, 2024. The contract is a firm fixed-price arrangement, without any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,261,614 units of the pharmaceutical drug Tamsulosin HCL 0.4 mg capsules. The $2,310.04 award has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00, through which this delivery order was issued. The contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order contract from the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,564,097,622 units of Tamsulosin HCl 0.4 mg capsules. The contract has a firm fixed price of $1,881.97 and a period of performance through March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation indicated. The contract is part of a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,618,995 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $8,489.68 and an Ultimate Completion Date of March 19, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,015,173 units of Tamsulosin HCL 0.4 mg capsules. The $6,301.70 contract has a period of performance through March 20, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which...